Limiting-Competition-under-SAT_ACC -_Redacted.pdf
PDF 101 KB Posted
- Solicitation number
- W81K0020F0227
- Issued by
-
Department of the Army Medical Command
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Radiopharmaceuticals Control No: 21-RHCO-C-117
Version – February 2017
Memorandum for Record – Limiting Competition at or below the Simplified
Acquisition Threshold
1. Contracting Activity: REGIONAL HEALTH CONTRACTING OFFICE-C 36000 Darnall Loop Room M1013 Fort Hood, Texas 76544
2. Description of Action:
Nature: New Requirement ☒ Follow-on Requirement W81K0019P0329
Contract Vehicle: ☒ BPA W81K0020A0009 Purchase Order Number 0011506990
Pricing/Contract Type: ☒ Fixed Price
Funds: ☒ Other Funds: DHP
FY: 21
Name of Proposed Contractor(s) and Address:
Cardinal Health 414, LLC 7000 Cardinal Place Dublin, Ohio 43017-1091
Brand Name Buy: ☒ Yes
3. Description of Services or Supplies: The items requested are for General Leonard Wood Army Community Hospital (GLWACH), Fort Leonard Wood, Missouri for radiopharmaceutical products that are specifically designed to be used for diagnostic and therapeutic purposes in the Department of Radiology, Nuclear Medicine section.
This request is subject to the availability of FY21 funds.
Base Period: 01 October 2020 to 30 September 2021 Value: $175,000.00
Total: $175,000.00
4. Authority:
☒ FAR 13.106-1(b)(1): For purchases not exceeding the simplified acquisition threshold (SAT), only one source reasonably available, urgency, exclusive licensing agreements, brand name, or industrial mobilization.
Version – February 2017
5. Reasons for Authority Cited:
The government has a continuing need to provide radiopharmaceutical products as needed during FY21. Radiopharmaceuticals are required by GLWACH Nuclear Medicine Department for cardiological, oncological, neurological and general nuclear medical assessment, diagnosis and treatment of patients. Radiopharmaceuticals are precise and must be matched to the actual procedure and for the specific patient requirements. There is a competed multiple award Blanket Purchase Agreement that has been issued, however Cardinal Health LLC is currently the only vendor of the multi award BPA’s that can meet GLWACH’s requirements of delivering required isotopes that can currently meet the unit of measure and specific calibrations that are required by the Department of Nuclear Medicine. There are six established BPA's for radiopharmaceuticals available to MTFs within the Regional Health Command- Central's (RHC-C) area of responsibility. GLWACH’S Nuclear Medicine Service selects and orders a particular required radiopharmaceutical based on specific treatment need in combination with timely availability for which Cardinal Health's radiopharmaceutical pharmacy, in certain cases, is the only source which can meet a specific requirement.
6. Publicizing Contract Actions: For FAR Part 13 actions, the public display and synopsis requirements of FAR 5.101 and FAR 5.203 ☒ do not apply due to the $ threshold.
7. Market Research: Initial market research revealed that the suggested vendor, a large business, was the only company that could provide all of the products that are needed for this requirement. Although the competed requirement produced the multiple award BPA’s for radiopharmaceuticals the other companies currently cannot provide the specific unit of measure and the required calibrations requested by GLWACH and currently can only be fulfilled by Cardinal Health, 414, LLC. The BPA’s are a result of a competitive action and solicitation. However in the future we will utilize and determine through market research if the item can be solicited through a government point of entry such as FedBizOps.
8. Other Facts: For future actions, the Government will reassess the market for available vendors, including but not limited to, issuing a Sources Sought Notice to determine market availability for brand name, or equal requirements. The current multiple award suite of radiopharmaceutical BPAs were a result of competitive solicitation and award. It is anticipated as the suite of BPAs expire the follow-on solicitation of BPAs will be similarly competitive. A Special Notice of Intent for the proposed limited source award will be posted on Federal Business Opportunities for which any responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency for future requirements. When the current requirement reaches the end of its time frame, becomes obsolete or when equivalent appropriate maintenance and repair services become available every effort shall be made to increase competition and therefore an evaluation shall also be made concerning pertinent services. GLWACH in conjunction with MEDCOM will continue to evaluate the capabilities of other vendor's services in order to provide items that are of
Version – February 2017 the best value to the Government. The Government will continue to seek new resources that will satisfy these requirements through continued market research, requests for Statements of Capability, and telephonic inquiries.
9. Technical/Requirements Certification: I certify that the supporting data under my cognizance which are included in the justification are accurate and complete to the best of my knowledge and belief.
Typed Name:
Date: 23 September 2020 Title:
Signature:
R
10. Contracting Officer Certification/Approval:
I hereby determine that the anticipated cost or price to the Government for this contract action will be fair and reasonable based upon proprietary and historical acquisition data.
I certify that this justification is accurate and complete to the best of my knowledge and belief, and that completing this purchase as a sole source is in the best interest of the Government. Additionally, I approve this justification to limit competition subject to the availability of funds and provided that the services or supplies herein described have otherwise been authorized for acquisition.
Typed Name:
Date: 23 September 2020 Title:
Signature:
Reviewed and Approved by , 23Sep2020
File details come from the government source that posted it. Updated .